Dr. Shikha Bharaktiya, MD (she/her) is an Endocrinologist in Houston, TX with over 15 years of experience. What is your opinion of Dr. Shikha Bharaktiya, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Shikha Bharaktiya, MD has received over $23,317 which includes payments from the following companies:
$8,241.29 from Novo Nordisk Inc
$4,338.86 from Shire North American Group Inc
$2,247.49 from Valeritas, Inc.
$1,768.19 from Tandem Diabetes Care, Inc.
$1,155.72 from sanofi-aventis U.S. LLC
$746.05 from AstraZeneca Pharmaceuticals LP
$573.95 from LILLY USA, LLC
$455.30 from Abbott Laboratories
$393.96 from Merck Sharp & Dohme Corporation
$331.39 from AbbVie, Inc.
$301.79 from INSULET CORPORATION
$251.64 from GlaxoSmithKline, LLC.
$243.20 from Boehringer Ingelheim Pharmaceuticals, Inc.
$239.87 from Animas Corporation
$236.87 from Amgen Inc.
$204.19 from Janssen Pharmaceuticals, Inc
$200.98 from Takeda Pharmaceuticals America, Inc.
$177.25 from MannKind Corporation
$167.69 from IBSA Pharma Inc.
$157.23 from VIVUS, Inc.
Payments received by Dr. Shikha Bharaktiya, MD were from the following categories:
$11,592.38 Food and Beverage
$6,716.25 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!